Table 1 Estimates of the genomic variance (\({{{\upsigma}}}_{{{g}}}^{2}\)) and heritability (\({{h}}_{{{g}}}^{2}\)) for VNN symptomatology, 95% highest posterior density interval (HPD95%) for \({{h}}_{{{g}}}^{2}\) and probability for \({{h}}_{{{g}}}^{2}\) to be greater than 0.2 obtained with three Bayesian regression models